Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.

Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.

Item
http://www.wikidata.org/entity/Q34069325
Label-free quantitative proteomics and N-terminal analysis of human metastatic lung cancer cells.Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibody.Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis.Phosphoproteomics and lung cancer research.Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma.Prognostic and diagnostic potential of isocitrate dehydrogenase 1 in esophageal squamous cell carcinoma.Non-small-cell lung cancers: a heterogeneous set of diseases.Relative protein quantification and accessible biology in lung tumor proteomes from four LC-MS/MS discovery platforms.Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach.IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.[Research Progress of Biomakers Proteomics-based in Lung Cancer].Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma
P2860

Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.

Item
http://www.wikidata.org/entity/Q34069325
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of isocitrate d ...... cancer by proteomic analysis.
@ast
Identification of isocitrate d ...... cancer by proteomic analysis.
@en
Identification of isocitrate d ...... cancer by proteomic analysis.
@nl
type
label
Identification of isocitrate d ...... cancer by proteomic analysis.
@ast
Identification of isocitrate d ...... cancer by proteomic analysis.
@en
Identification of isocitrate d ...... cancer by proteomic analysis.
@nl
prefLabel
Identification of isocitrate d ...... cancer by proteomic analysis.
@ast
Identification of isocitrate d ...... cancer by proteomic analysis.
@en
Identification of isocitrate d ...... cancer by proteomic analysis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Identification of isocitrate d ...... g cancer by proteomic analysis
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932